Colorectal Cancer

Colorectal Cancer Quality Measures

Cleveland Clinic is accredited by the National Accreditation Program for Rectal Cancer (NAPRC) which was developed through a collaboration between the OSTRiCh Consortium (Optimizing the Surgical Treatment of Rectal Cancer) and the Commission on Cancer (CoC), a quality program of the American College of Surgeons. The NAPRC's goal is to ensure patients with rectal cancer receive appropriate care using a multidisciplinary approach. NAPRC accreditation signifies demonstration of several rectal cancer care processes and quality metrics that have been proven to improve outcomes.

Quality: At Least 12 Lymph Nodes Removed and Examined Pathologically for Patients Undergoing Resection for Colon Cancer (N = 155)


NCDC = National Cancer Database

ᵃThe National Cancer Database is a nationwide oncology outcomes database and is a joint program of the Commission on Cancer and the American Cancer Society.

Cleveland Clinic's performance was 97.4% (150 of 155 patients; 95% CI, 94.9%-99.9%) in 2020 for this National Cancer Databaseᵃ standard of care quality measure, exceeding the 85% standard performance rate.

Percentage of Rectal Cancer Patients Presented at Pre-Treatment Tumor Boards)


Cleveland Clinic's performance was 96% in 2021 for rectal cancer patients presented at tumor boards.